Aktienanalyse zu Change Agents Corporation (CHGA)CHGAChange Agents Corporation

Change Agents Corp., formerly Avalon GloboCare Corp., is an artificial intelligence software company. The Company is focused on developing agentic artificial intelligence (AI) applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The Company's portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its Software-as-a-Service (SaaS) business model, the Company is focused on delivering innovative AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns. The Company is also distributing the KetoAir breathalyzer device, a non-invasive consumer breathalyzer that measures ketosis levels and is sold in North America. It operates in the Real Estate sector.

Currently, Change Agents Corporation (CHGA) is not a good buy due to its poor financial performance and negative trends. The stock has a current price of 1.65, with a year-to-date change of -70.74%, indicating significant losses. Additionally, the RSI is at 43.974, suggesting it is nearing oversold conditions but not yet a strong buy signal. The main risk is the negative net income of -4479695.00 for Q1 2026, which raises concerns about the company's profitability and sustainability.